BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 10523222)

  • 1. Prescribing hormone replacement therapy for menopausal symptoms.
    McNagny SE
    Ann Intern Med; 1999 Oct; 131(8):605-16. PubMed ID: 10523222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy for the management of menopause symptoms.
    Collins Fantasia H; Sutherland MA
    J Obstet Gynecol Neonatal Nurs; 2014; 43(2):226-35; quiz E18-9. PubMed ID: 24502325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to the patient with menopausal symptoms.
    Martin KA; Manson JE
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new verdict for hormone therapy: safe for younger women.
    Knotts JL; Childers WA
    JAAPA; 2009 Dec; 22(12):46-51. PubMed ID: 24887468
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical practice. Management of menopausal symptoms.
    Grady D
    N Engl J Med; 2006 Nov; 355(22):2338-47. PubMed ID: 17135587
    [No Abstract]   [Full Text] [Related]  

  • 6. Helping women stop postmenopausal hormone therapy.
    Grady D
    Menopause; 2006; 13(3):323-4. PubMed ID: 16735925
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone replacement therapy and beyond. The clinical challenge of menopausal symptoms in breast cancer survivors.
    Mortimer JE
    Geriatrics; 2002 Sep; 57(9):25-31. PubMed ID: 12271826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of menopause management and menopausal related hormone replacement therapy].
    Yu Q
    Zhonghua Fu Chan Ke Za Zhi; 2013 Apr; 48(4):287-90. PubMed ID: 23902813
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 10. How best is to discontinue postmenopausal hormone therapy: immediate or tapered?
    Aslan E; Bagis T; Kilicdag EB; Tarim E; Erkanli S; Kuscu E
    Maturitas; 2007 Jan; 56(1):78-83. PubMed ID: 17046182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we predict who will experience recurrent vasomotor symptoms after stopping hormone therapy?
    Gracia CR; Sondheimer S
    Menopause; 2010; 17(1):10-1. PubMed ID: 20010441
    [No Abstract]   [Full Text] [Related]  

  • 12. 'Feeling hot, hot, hot': is there a role for exercise in the management of vasomotor and other menopausal symptoms?
    Daley AJ; Stokes-Lampard H; MacArthur C
    J Fam Plann Reprod Health Care; 2007 Jul; 33(3):143-5. PubMed ID: 17609065
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone Therapy and Other Treatments for Symptoms of Menopause.
    Hill DA; Crider M; Hill SR
    Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations.
    Kapoor E; Benrubi D; Faubion SS
    Clin Obstet Gynecol; 2018 Sep; 61(3):488-495. PubMed ID: 29762148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient information. Hormone replacement therapy: frequently asked questions.
    Cleve Clin J Med; 2002 Sep; 69(9):680-1. PubMed ID: 12222971
    [No Abstract]   [Full Text] [Related]  

  • 16. Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women.
    Worsley R; Bell RJ; Gartoulla P; Davis SR
    Menopause; 2016 Jan; 23(1):11-7. PubMed ID: 26240945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormonal therapy in gynaecological cancers: An evidence-based approach for clinical management.
    Fenton CL; McGauran MJ; Richards AM
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):942-945. PubMed ID: 32815168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women.
    Kelley KW; Carroll DG
    J Am Pharm Assoc (2003); 2010; 50(5):e106-15. PubMed ID: 20833608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence.
    Garefalakis M; Hickey M
    Clin Interv Aging; 2008; 3(1):1-8. PubMed ID: 18488873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.